Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: Report of two cases and review of the literature

Yuko Kaneko, Akira Suwa, Yasuo Ikeda, Michito Hirakata

研究成果: Article査読

28 被引用数 (Scopus)

抄録

Low-dose methotrexate (MTX) therapy is widely used for rheumatoid arthritis (RA) because of its favorable efficacy and toxicity profile. Although Pneumocystis jiroveci pneumonia (PCP) is most often seen in severely immunosuppressed patients, PCP complicating low-dose MTX therapy for RA has been reported to sometimes occur. We herein report two cases of patients who developed PCP during treatment with low-dose MTX, and discuss the importance of prophylaxis for this opportunistic infection.

本文言語English
ページ(範囲)36-38
ページ数3
ジャーナルModern rheumatology
16
1
DOI
出版ステータスPublished - 2006 2

ASJC Scopus subject areas

  • Rheumatology

フィンガープリント 「Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: Report of two cases and review of the literature」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル